CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Grant or award SVP, General Counsel acquired 40,209 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 48,581 shares (grant or award)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 8,146 shares at an average $254.58 ($2,073,826)
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Open-market sale Chief Executive Officer sold 101,000 shares at an average $244.30 ($24,674,638)
- 144 Insider Sale of Securities
- 4 Open-market sale President, COO & GM China sold 0 shares
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 4 Planned sale SVP, General Counsel sold 1,205 shares at $275.00 ($331,375)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 732,827 shares at $260.00 ($190,535,020)
- 10-K/A Report 10-K/A
- S-4/A Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 15 of 64 · 1,278 filings